By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Phone: Fax:


Company News
Merrimack (MACK) And Baxalta (BXLT) Announce Publication Of The ONIVYDE (irinotecan liposome injection) NAPOLI-1 Study In The Lancet 11/23/2015 6:39:29 AM
PharmaEngine, Inc. Announces The Lancet Publication Of The ONIVYDE Phase 3 NAPOLI-1 Study 11/23/2015 6:26:11 AM
Maternal Mortality Falls By Almost 50%, Lancet Publishes 11/12/2015 7:14:34 AM
St. Jude Medical (STJ) Release: New Long-Term Data Published In The Lancet Further Demonstrates Superiority Of The Cardiomems HF System Over Standard Of Care 11/9/2015 10:58:46 AM
Elekta Release: Phase III Data Published in The Lancet Show Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy Is Clinically Equivalent To Whole Breast Irradiation In Early Stage Cancer 10/20/2015 10:16:40 AM
Results From Merck & Co. (MRK)’s Phase 3 Study Of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir In Patients With Advanced Chronic Kidney Disease Published In Lancet 10/6/2015 12:01:00 PM
Inovio Pharma (INO) Publishes Successful Phase 2b Trial Results Of Its HPV Immunotherapy In The Lancet Lancet 9/17/2015 6:17:27 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ (tasimelteon) Phase III SET And RESET Trial Results Published In The Lancet 8/5/2015 10:44:05 AM
Isis Pharma (ISIS) Release: Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published In The Lancet 7/23/2015 8:48:29 AM
The Lancet Infectious Diseases Journal Publishes Results Of Phase II Study Of Lonafarnib In Hepatitis Delta Virus (HDV) Infected Patients 7/20/2015 7:48:28 AM